Kewaunee Scientific (KEQU) Proxy filing summary

Executive summary

• Annual Meeting scheduled for August 26, 2026, to be held virtually, with shareholders able to vote and ask questions online.

• Key agenda items include election of three Class I directors, ratification of the independent auditor, and an advisory vote on executive compensation.

• Proxy materials are distributed electronically to reduce costs and environmental impact.

Voting matters and shareholder proposals

• Shareholders will vote on electing three Class I directors, ratifying Forvis Mazars, LLP as independent auditors for FY 2027, and approving executive compensation on an advisory basis.

• Shareholder proposals for the 2027 meeting must be submitted by March 9, 2027, with additional requirements for proxy solicitation under universal proxy rules.

Board of directors and corporate governance

• Board consists of three classes of directors with staggered terms; all but one director are independent.

• Four standing committees: Audit, Compensation, Financial/Planning, and Nominating and Corporate Governance, all composed of independent directors.

• Board leadership structure separates Chairman and CEO roles; all directors attended at least 75% of meetings in FY 2026.

• Stock ownership guidelines require directors to hold stock equal to three times their annual retainer.

• Code of Ethics and compliance hotline in place; insider trading policy filed with the SEC.